Corcept Therapeutics (CORT) Shares Repurchased (2018 - 2025)
Historic Shares Repurchased for Corcept Therapeutics (CORT) over the last 6 years, with Q3 2025 value amounting to $42.5 million.
- Corcept Therapeutics' Shares Repurchased rose 26263.02% to $42.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $172.9 million, marking a year-over-year increase of 100390.07%. This contributed to the annual value of $15.7 million for FY2024, which is N/A changed from last year.
- According to the latest figures from Q3 2025, Corcept Therapeutics' Shares Repurchased is $42.5 million, which was up 26263.02% from $103.0 million recorded in Q2 2025.
- Corcept Therapeutics' 5-year Shares Repurchased high stood at $119.0 million for Q4 2021, and its period low was $476000.0 during Q1 2024.
- Moreover, its 3-year median value for Shares Repurchased was $28.3 million (2021), whereas its average is $39.6 million.
- In the last 5 years, Corcept Therapeutics' Shares Repurchased soared by 1209672.73% in 2021 and then skyrocketed by 26263.02% in 2025.
- Corcept Therapeutics' Shares Repurchased (Quarter) stood at $119.0 million in 2021, then plummeted by 90.16% to $11.7 million in 2024, then surged by 262.63% to $42.5 million in 2025.
- Its Shares Repurchased was $42.5 million in Q3 2025, compared to $103.0 million in Q2 2025 and $27.4 million in Q1 2025.